Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

CDC42 and multiple sclerosis are reported together in 1 article.

Gene

CDC42

HGNC
HGNC:1736
11articles
11mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
236articles
236mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

1 records shown · first 60

An Integrated Network Biology and Molecular Dynamics Approach Identifies CD44 as a Promising Therapeutic Target in Multiple Sclerosis.

PMID 41754795 | PMCID PMC12943740 | DOI 10.3390/ph19020254 · Pharmaceuticals (Basel, Switzerland) · 2026 · 4 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneCDC42“Results: There were 1200 genes found to be differentially expressed, with CD44 showing the highest degree score of 15, followed by CDC42 and SNAP25 genes, each with a degree score of 14.”0.98hgnc_dict_v1
phenotypemultiple sclerosis“An Integrated Network Biology and Molecular Dynamics Approach Identifies CD44 as a Promising Therapeutic Target in Multiple Sclerosis.”0.98phenotype_alias_lexicon_v2
geneCD44“An Integrated Network Biology and Molecular Dynamics Approach Identifies CD44 as a Promising Therapeutic Target in Multiple Sclerosis.”0.98hgnc_dict_v1
geneSNAP25“Results: There were 1200 genes found to be differentially expressed, with CD44 showing the highest degree score of 15, followed by CDC42 and SNAP25 genes, each with a degree score of 14.”0.98hgnc_dict_v1